400 related articles for article (PubMed ID: 10632534)
21. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
[TBL] [Abstract][Full Text] [Related]
22. Failure of Helicobacter pylori eradication: is poor compliance the main cause?
Wermeille J; Cunningham M; Dederding JP; Girard L; Baumann R; Zelger G; Buri P; Metry JM; Sitavanc R; Gallaz L; Merki H; Godin N
Gastroenterol Clin Biol; 2002 Mar; 26(3):216-9. PubMed ID: 11981460
[TBL] [Abstract][Full Text] [Related]
23. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
24. Dual versus triple therapy in eradication of Helicobacter pylori.
Ohlin B; Cederberg A; Kjellin T; Kullman E; Melén K; von Holstein CS; Thoring M
Hepatogastroenterology; 2002; 49(43):172-5. PubMed ID: 11941946
[TBL] [Abstract][Full Text] [Related]
25. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
26. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Gisbert JP; Gisbert JL; Marcos S; Pajares JM
Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
[TBL] [Abstract][Full Text] [Related]
27. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
28. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori antibiotic resistance in a Dutch region: trends over time.
Janssen MJ; Hendrikse L; de Boer SY; Bosboom R; de Boer WA; Laheij RJ; Jansen JB
Neth J Med; 2006 Jun; 64(6):191-5. PubMed ID: 16788217
[TBL] [Abstract][Full Text] [Related]
30. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
[TBL] [Abstract][Full Text] [Related]
31. Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy.
Mégraud F
Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S35-7; discussion S43-5. PubMed ID: 10503821
[TBL] [Abstract][Full Text] [Related]
32. Eradication of Helicobacter pylori followed by reinfection.
Tonokatsu Y; Fukuda Y; Tsujiai T; Tamura K; Shimoyama T
J Gastroenterol; 1996 Nov; 31 Suppl 9():75-6. PubMed ID: 8959526
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of clarithromycin in eradicating Helicobacter pylori.
Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
[TBL] [Abstract][Full Text] [Related]
34. [Eradication of Helicobacter pylori by triple therapy in ulcerous patients: the role of endoscopy and antibiotic sensitivity].
Garrido A; Lepe JA; Guerrero FJ; Palomo S
Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):471-3. PubMed ID: 9918994
[TBL] [Abstract][Full Text] [Related]
35. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Kawano S; Murakami M; Saita H; Tsuji S
J Gastroenterol; 1996 Nov; 31 Suppl 9():41-3. PubMed ID: 8959517
[TBL] [Abstract][Full Text] [Related]
36. Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
Arenz T; Antos D; Rüssmann H; Alberer M; Buderus S; Kappler M; Koletzko S
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):180-4. PubMed ID: 16877981
[TBL] [Abstract][Full Text] [Related]
37. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
38. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Inoue K; Sugano K
Nihon Rinsho; 2002 Feb; 60 Suppl 2():460-4. PubMed ID: 11979828
[No Abstract] [Full Text] [Related]
39. The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia.
Tüzün Y; Bayan K; Yilmaz S; Dursun M; Ozekinci T
Hepatogastroenterology; 2008; 55(81):289-93. PubMed ID: 18507127
[TBL] [Abstract][Full Text] [Related]
40. [Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori].
Sakurai K; Takahashi H; Yamaguchi Y; Yamada M; Kirihara K; Kojima T; Fujita R
Nihon Rinsho; 1999 Jan; 57(1):72-5. PubMed ID: 10036938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
